Daiwa Securities Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29M Sell
477,467
-67,929
-12% -$3.96M 0.08% 135
2025
Q4
$29.4M Buy
545,396
+21,854
+4% +$1.05M 0.09% 138
2025
Q3
$23.6M Buy
523,542
+15,456
+3% +$722K 0.08% 158
2025
Q2
$23.5M Buy
508,086
+83,427
+20% +$4.1M 0.09% 150
2025
Q1
$25.9M Buy
424,659
+102,664
+32% +$5.98M 0.11% 116
2024
Q4
$18.2M Sell
321,995
-8,196
-2% -$458K 0.08% 154
2024
Q3
$17.1M Buy
330,191
+78,309
+31% +$3.67M 0.08% 154
2024
Q2
$10.5M Buy
251,882
+40,369
+19% +$1.81M 0.06% 194
2024
Q1
$11.5M Buy
211,513
+20,988
+11% +$1.07M 0.06% 170
2023
Q4
$9.78M Buy
190,525
+12,160
+7% +$638K 0.06% 173
2023
Q3
$10.4M Buy
178,365
+7,438
+4% +$456K 0.07% 152
2023
Q2
$10.9M Buy
170,927
+1,940
+1% +$130K 0.07% 152
2023
Q1
$11.7M Buy
168,987
+11,115
+7% +$784K 0.08% 137
2022
Q4
$11.4M Buy
157,872
+10,524
+7% +$794K 0.09% 143
2022
Q3
$10.5M Sell
147,348
-3,528
-2% -$256K 0.09% 133
2022
Q2
$11.6M Buy
150,876
+12,473
+9% +$950K 0.09% 120
2022
Q1
$10.1M Buy
138,403
+4,561
+3% +$306K 0.06% 165
2021
Q4
$8.35M Buy
133,842
+5,118
+4% +$300K 0.05% 199
2021
Q3
$7.62M Sell
128,724
-5,425
-4% -$357K 0.05% 191
2021
Q2
$8.96M Sell
134,149
-3,536
-3% -$231K 0.06% 152
2021
Q1
$8.69M Sell
137,685
-75,661
-35% -$4.71M 0.06% 142
2020
Q4
$13.2M Buy
213,346
+84,301
+65% +$5.18M 0.1% 102
2020
Q3
$7.78M Sell
129,045
-11,444
-8% -$689K 0.07% 125
2020
Q2
$889K Hold
140,489
0.02% 397
2020
Q1
$7.83M Buy
140,489
+6,414
+5% +$392K 0.08% 121
2019
Q4
$8.61M Buy
134,075
+62,275
+87% +$3.57M 0.07% 128
2019
Q3
$3.64M Buy
71,800
+5,531
+8% +$260K 0.03% 241
2019
Q2
$3.01M Sell
66,269
-16,250
-20% -$757K 0.03% 260
2019
Q1
$3.94M Sell
82,519
-28,485
-26% -$1.42M 0.03% 211
2018
Q4
$5.77M Sell
111,004
-63,530
-36% -$3.41M 0.06% 155
2018
Q3
$10.8M Sell
174,534
-19,250
-10% -$1.14M 0.09% 112
2018
Q2
$10.7M Sell
193,784
-4,294
-2% -$232K 0.08% 118
2018
Q1
$12.5M Buy
198,078
+46,631
+31% +$3M 0.1% 101
2017
Q4
$9.28M Sell
151,447
-42,100
-22% -$2.63M 0.07% 151
2017
Q3
$12.3M Buy
193,547
+38,991
+25% +$2.28M 0.08% 108
2017
Q2
$8.61M Sell
154,556
-91,547
-37% -$4.98M 0.06% 134
2017
Q1
$13.4M Sell
246,103
-25,657
-9% -$1.41M 0.08% 103
2016
Q4
$15.9M Sell
271,760
-74,110
-21% -$4.05M 0.1% 71
2016
Q3
$18.6M Sell
345,870
-46,370
-12% -$2.98M 0.11% 73
2016
Q2
$28.8M Buy
392,240
+14,570
+4% +$1.03M 0.17% 52
2016
Q1
$24.1M Sell
377,670
-78,600
-17% -$4.96M 0.15% 54
2015
Q4
$31.4M Sell
456,270
-13,190
-3% -$872K 0.21% 44
2015
Q3
$27.8M Buy
469,460
+107,430
+30% +$6.82M 0.2% 52
2015
Q2
$24.1M Buy
362,030
+170,730
+89% +$11.3M 0.17% 61
2015
Q1
$12.3M Buy
191,300
+22,130
+13% +$1.39M 0.08% 89
2014
Q4
$9.99M Buy
169,170
+108,060
+177% +$6.09M 0.07% 95
2014
Q3
$3.13M Buy
61,110
+17,410
+40% +$870K 0.02% 180
2014
Q2
$2.12M Sell
43,700
-76,500
-64% -$3.77M 0.02% 220
2014
Q1
$6.24M Buy
120,200
+1,900
+2% +$101K 0.05% 133
2013
Q4
$6.29M Sell
118,300
-36,000
-23% -$1.83M 0.05% 125
2013
Q3
$7.14M Sell
154,300
-20,000
-11% -$878K 0.06% 121
2013
Q2
$7.79M Buy
+174,300
New +$7.57M 0.06% 118

Other funds holding BMY

Daiwa Securities Group's BMY Position: Q1 2026 in Review

Daiwa Securities Group reduced its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, selling an estimated $3.96M and leaving 477,467 shares worth $29M. The position accounts for 0.08% of the portfolio, ranked #135.

Daiwa Securities Group first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.4M in Q4 2015. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Daiwa Securities Group held 477,467 shares of Bristol-Myers Squibb worth $29M as of Q1 2026.
  • Daiwa Securities Group sold 67,929 Bristol-Myers Squibb shares in Q1 2026, an estimated $3.96M.
  • Bristol-Myers Squibb made up 0.08% of Daiwa Securities Group's portfolio in Q1 2026, its #135 holding.
  • Daiwa Securities Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Daiwa Securities Group's Bristol-Myers Squibb position peaked at $31.4M in Q4 2015.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.